Skip to main content
SpringerLink
Log in
Book cover

The SAGES Manual of Bariatric Surgery pp 225–237Cite as

Index Endoscopic Restrictive and Other Devices in Obesity Treatment: Techniques and Outcomes

  • Chapter
  • First Online:

  • 1595 Accesses

Abstract

This chapter describes the major intragastric endoscopic restrictive devices currently in use and in development to aid in weight loss for the obese patient. By far the most commonly used and prolific of these devices is the intragastric balloon, of which three types are now FDA approved in the USA, with others available internationally. Many thousands of patients have had such balloons placed, usually for up to 6 months per balloon. Other devices approved for gastric suturing have been adapted for weight reduction procedures, such as the endoscopic sleeve gastroplasty. Space-occupying products of other types, including stents, expanding ingested beads, and devices which partially obstruct the pylorus are also described.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hogan RB, Johnston JH, Long BW, et al. A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity. Gastrointest Endsc. 1989;35(3):381–5.

    Article  CAS  Google Scholar 

  2. Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15(8):1161–4.

    Article  CAS  PubMed  Google Scholar 

  3. Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14(7):991–8.

    Article  PubMed  Google Scholar 

  4. Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18(7):841–6.

    Article  PubMed  Google Scholar 

  5. ASGE Bariatric Endoscopy Task force and ASGE technology committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–38.

    Article  Google Scholar 

  6. http://www.accessdata.fda.gov/cdrh_docs/pdf14/P14008 b.pdf

  7. Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Rel Dis. 2015;11(4):874–81.

    Article  Google Scholar 

  8. http://www.accessdata.fda.gov/cdrh_docs/pdf14/P140012 b.pdf

  9. DePeppo F, Caccamo R, Adorisio O, et al. The Obalon swallowable intragastric balloon in pediatric and adolescent morbid obesity. Endosc Int Open. 2017;5:E59–63.

    Article  Google Scholar 

  10. Brooks J, Srivasta ED, Mathus-Vligen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg. 2014;24:813–9.

    Article  CAS  PubMed  Google Scholar 

  11. Machytka E, Puig Divi V, Saenger F, et al. Adjustable balloons for weight loss: a higher yield of responders compared with non-adjustable balloons. Chicago: ASGE Poster Session, Digestive Disease Week; 2017.

    Google Scholar 

  12. Raftopoulos I, Giannakou A. The Elipse balloon, a swallowable gastric balloon for weight loss not requiring sedation, anesthesia, or endoscopy: a pilot study with 12-month outcomes. Surg Obes Rel Dis. 2017;13:1174–82.

    Article  Google Scholar 

  13. Tate CM, Geliebter A. Intragastric balloon treatment for obesity: review of recent studies. Adv Ther 2017;34(8):1859–75.

    Google Scholar 

  14. “Liquid filled intragastric balloon systems: Letter to healthcare providers – potential risks.” FDA safety alert. Published August 8, 2017. https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm570916.htm

  15. “Smart pill” reduces weight in overweight and obese subjects. ScienceDaily 2014; Available at: http://www.sciencedaily.com/releases/2014/06/140623141859.htm. Accessed July 13, 2015.

  16. Sharaiha RZ, Kumta NA, DeFillipis DM, et al. A large multicenter experience with endoscopic suturing for management of gastrointestinal defects and stent anchorage in 122 patients: a retrospective review. J Clin Gastroenterol. 2016;50:388–92.

    PubMed  Google Scholar 

  17. Vargas EJ, Bazerbachi F, Rizk M, et al. Transoral outlet reduction with full thickness endoscopic suturing for weight regain after gastric bypass: a large multicenter international experience and meta-analysis. Surg Endosc. 2017 epub ahead of print 2017 June 29 https://doi.org/10.1007/s00464-017-5671-1.

  18. Lopez-Nava G, Sharaiha RZ, Vargas EJ, et al Endoscopic sleeve gastroplasty for morbid obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 2017;27(10):2644–55.

    Google Scholar 

  19. Sharaiha RZ, Kumta NA, Saumoy M, et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol. 2017;15:504–10.

    Article  PubMed  Google Scholar 

  20. Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology. 2017;152(7):1791–801.

    Article  PubMed  Google Scholar 

  21. Marinos G, Eliades C, Raman Muthusamy V, Greenway F. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis. 2014;10(5):929–34.

    Article  PubMed  Google Scholar 

  22. Bazerbachi F, Vargas Valls EJ, Abu Dayyeh BK. Recent clinical results of endoscopic bariatric therapies as an obesity intervention. Clin Endosc. 2017;50(1):42–50.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Dayyeh A, BK ESA, Jonnalagada S, et al. ASGE endoscopy bariatric task force; ASGE technology committee. Endosc Baria Ther Gastrointest Endosc. 2015;81(5):1073–86.

    Article  Google Scholar 

  24. Dargent J. Innovative technologies and non-invasive procedures in bariatric surgery, vol. 27. New York: Springer Science; 2013.

    Book  Google Scholar 

  25. Bariatric News; Prevail Implant System; Studies show new bariatric implant is “safe and effective. July 2012. http://www.bariatricnews.net/?q=node/336.

  26. Kumar N. Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World J Gastrointest Endosc. 2015;7(9):847–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Sauer N, Rösch T, Pezold J, et al. A new endoscopically implantable device (SatiSphere) for treatment of obesity–efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels. Obes Surg 2013 23(11):1727–33.

    Google Scholar 

  28. Fiona Sander. Clinical investigation report: pre-market study to investigate the safety and performance of the SatiSphere® Duodenal insert in overweight and obese patients. CRO Medpace: 2017.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Virginia Health System, Charlottesville, VA, USA

    Bruce Schirmer & Peter Adams

Authors
  1. Bruce Schirmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruce Schirmer .

Editor information

Editors and Affiliations

  1. Foregut and Bariatric Surgeon, Division of Gastrointestinal and Minimally Invasive Surgery, The Oregon Clinic, Portland, Oregon, USA

    Kevin M. Reavis

  2. Long Island Jewish Forest Hills Hospital, Department of Surgery, Hofstra-Northwell School of Medicine, Forest Hills, New York, USA

    Allison M. Barrett

  3. Institute Chief, Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

    Matthew D. Kroh

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schirmer, B., Adams, P. (2018). Index Endoscopic Restrictive and Other Devices in Obesity Treatment: Techniques and Outcomes. In: Reavis, K., Barrett, A., Kroh, M. (eds) The SAGES Manual of Bariatric Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-71282-6_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71282-6_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71281-9

  • Online ISBN: 978-3-319-71282-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation